Company Directory / research

PrivateFor profitresearchColumbus, United States
Forge Biologics is a gene therapy development engine, enabling access to life changing gene therapy programs.
Size
251-500 people: larger than 92% of companies with a size listed
Age
6 years old.
Reach
Website ranked #2,953,405 in the world for traffic, about 5k visits a month.
BiotechnologyHealth CareMedicalTherapeutics
Funding, as listed
$330M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Forge Biologics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
Corporate family
About this record
Growth, as the source summarises it
Forge Biologics may be growing as evidenced by its acquisition by a Japanese firm for $620 million, which indicates a significant valuation and interest from larger entities in the biotechnology and therapeutics industry. The acquisition by Ajinomoto, a company looking to boost its gene therapy capabilities, suggests that Forge Biologics has developed valuable assets and expertise in this field. Furthermore, the repeated mention of the acquisition across multiple news sources underscores the importance and impact of this event for Forge Biologics.
Summaries written by the source dataset, not by us, and not checked.
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.